Life on Sol (LIFE) news

Ethos Technologies President Wang Lingke Reports Sale of $4.54 Million in Common Shares

Ethos Technologies schedules Q3 financial results conference call

BUZZ-JPMorgan downgrades Ethos Technologies’ rating to “Neutral”; share price drops

U.S. Stock Market Movement: Ethos Technologies Surges on September 24; Target Price Raised Amid Insurtech Developments

「an exchange Life」 has surged over 21% in the past 24 hours, with a market capitalization currently standing at $456 million.

As of March 31, 2026, Wave Life Sciences Pte. Ltd (NASDAQ: WVE) announced its cash and cash equivalents reserves reached $544.6 millions.

Life Time to Report First Quarter 2026 Financial Results on May 5, 2026

Citizens, Inc. to Participate at Emerging Growth Virtual Conference on April 2, 2026

Wave Life Sciences Ltd. recently announced that it will launch two key clinical trials for incretin-based adjuvant therapies in 2026: the Inlight study and the phase IIa trial of the new WVE-007.

Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jim Cramer on Agilent Technologies: "I Don't Think You Need It"

Silicon Laboratories Inc. (SLAB) Announces Fourth Quarter and Full Year 2025 Results

Propanc Biopharma's Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models

Citi Raises Ethos Technologies Inc. (LIFE) Price Target to $16 from $15

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL (propranolol hydrochloride) Oral Solution

Crypto investment cons now run like call centers and the DOJ $580M haul shows where the money pools

Becton, Dickinson and Company (BDX): A Bull Case Theory

Morgan Stanley Reiterates Buy on Globe Life (GL) Shares

Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings

RBC Capital Lowers PT on Clarivate Plc (CLVT) Following Q4 2025 Results

Ethos to Participate in The Citizens Technology Conference

Here is Why ICON Public Limited Company (ICLR) Offers an Impressive Upside

Agilent Technologies, Inc. (A) Sparks Confidence With Latest Approvals

What To Expect From Agilent's (A) Q4 Earnings

MBX Biosciences to Participate in Upcoming March Investor Conferences

Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

BofA Raises W. P. Carey (WPC) Price Target as Net Lease Investment Activity Remains Strong

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

Why F&G Annuities & Life (FG) Stock Is Falling Today